To analyze the promoter methylation profile and mRNA expression of the p14ARF gene in oral squamous cell carcinoma (OSCC).
Methods
Promoter methylation of the p14ARF gene was investigated by methylation-specific polymerase chain reaction in paraffin-embedded tissues from 76 patients with OSCC and 57 oral tissues used as healthy controls. Expression of p14ARF mRNA was also determined using real-time quantitative reverse-transcription PCR. The methylation status and mRNA level profile of the gene and their relationship with clinical data were analyzed.
Results
Methylation of the p14ARF gene in OSCC was significantly increased compared to normal control tissues (χ2 = 16.73, p<0.0001). The relative expression of p14ARF mRNA in OSCC was not significantly different from that in healthy control samples.
Conclusion
Promoter methylation of p14ARF may be an important mechanism in OSCC, and its determination may be considered an important tool in the early diagnosis and treatment of OSCC.
World Health Organization.The World Health Report 2004 – Changing History.Geneva: WHO, 2004.
2.
MousaviS.M., GouyaM.M., RamazaniR., DavanlouM., HajsadeghiN., SeddighiZ.Cancer incidence and mortality in Iran.Ann Oncol2009; 20: 556–63.
3.
PetersenP.E.Oral cancer prevention and control–the approach of the World Health Organization.Oral Oncol2009; 45: 454–60.
4.
FeinbergA.P., VogelsteinB.Hypomethylation distinguishes genes of some human cancers from their normal counterparts.Nature1983; 301: 89–92.
5.
DingZ., QianYb, ZhuLx, xiongQ.R.Promoter methylation and mRNA expression of DKK-3 and WIF-1 in hepatocellular carcinoma.World J Gastroenterol2009; 15: 2595–601.
6.
RuasM., PetersG.The p16INK4a/CDKN2A tumor suppressor and its relatives.Biochim Biophys Acta1998; 1378: F115–77.
7.
SerranoM., HannonG.J., BeachD.A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.Nature1993; 366: 704–7.
8.
SherrC.J., RobertsJ.M.Inhibitors of mammalian G1 cyclin-dependent kinases.Genes Dev1995; 9: 1149–63.
9.
WeinbergR.A.The retinoblastoma protein and cell cycle control.Cell1995; 81: 323–30.
10.
KamijoT., WeberJ.D., ZambettiG., ZindyF., RousselM.F., SherrC.J.Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2.Proc Natl Acad Sci U S A1998; 95: 8292–7.
11.
KamijoT., ZindyF., RousselM.F.Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF.Cell1997; 91: 649–59.
12.
BerggrenP., KumarR., SakanoS.Detecting homozygous deletions in the CDKN2A(p16(INK4a))/ARF(p14(ARF)) gene in urinary bladder cancer using real-time quantitative PCR.Clin Cancer Res2003; 9: 235–42.
13.
EstellerM., TortolaS., ToyotaM.Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status.Cancer Res2000; 60: 129–33.
14.
SatoF., HarpazN., ShibataD.Hypermethylation of the p14(ARF) gene in ulcerative colitis-associated colorectal carcinogenesis.Cancer Res2002; 62: 1148–51.
15.
KangM.Y., LeeB.B., JiY.I.Association of interindividual differences in p14ARF promoter methylation with single nucleotide polymorphism in primary colorectal cancer.Cancer2008; 112: 1699–707.
16.
UhrinovaS., UhrinD., PowersH.Structure of free MDM2 N-terminal domain reveals conformational adjustments that accompany p53-binding.J Mol Biol2005; 350: 587–98.
17.
De JongW.K., VerpootenG.F., KramerH., LouwagieJ., GroenH.J.Promoter methylation primarily occurs in tumor cells of patients with non-small cell lung cancer.Anticancer Res2009; 29: 363–9.
18.
EllingerJ., AlbersP., PeraboF.G., MullerS.C., Von RueckerA., BastianP.J.CpG island hypermethylation of cell-free circulating serum DNA in patients with testicular cancer.J Urol2009; 182: 324–9.
19.
KuoL.T., KuoK.T., LeeM.J.Correlation among pathology, genetic and epigenetic profiles, and clinical outcome in oligodendroglial tumors.Int J Cancer2009; 124: 2872–9.
20.
PhéV., CussenotO., RouprêtM.Interest of methylated genes as biomarkers in urothelial cell carcinomas of the urinary tract.BJU Int2009, June 12 [Epub ahead of print].
21.
TaharaT., ShibataT., ArisawaT.Impact of catechol-O-methyltransferase (COMT) gene polymorphism on promoter methylation status in gastric mucosa.Anticancer Res2009; 29: 2857–61.
22.
SharmaG., MirzaS., PrasadC.P., SrivastavaA., GuptaS.D., RalhanR.Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients.Life Sci2007; 80: 1873–81.
23.
SailasreeR., AbhilashA., SathyanK.M., NalinakumariK.R., ThomasS., KannanS.Differential roles of p16INK4A and p14ARF genes in prognosis of oral carcinoma.Cancer Epidemiol Biomarkers Prev2008; 17: 414–20.
